Anti-MiRNA-based treatment for Hepatocarcinoma Intrahepatic Metastasis: Monocyte chemotactic protein-1 (MCP-1) suppresses the expression of tumor suppresor RECK via up regulation of its target gene, 3/July/2014, 6.17 am

Anti-MiRNA-based treatment for Hepatocarcinoma Intrahepatic Metastasis: Monocyte chemotactic protein-1 (MCP-1) suppresses the expression of tumor suppresor RECK via up regulation of its target gene, 3/July/2014, 6.17 am

Anti-MiRNA-based treatment for Hepatocarcinoma Intrahepatic Metastasis: Monocyte chemotactic protein-1 (MCP-1) suppresses the expression of tumor suppresor RECK via up regulation of its target gene, 3/July/2014, 6.17 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan PhD

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, L., Anti-MiRNA-based treatment for Hepatocarcinoma Intrahepatic Metastasis: Monocyte chemotactic protein-1 (MCP-1) suppresses the expression of tumor suppresor RECK via up regulation of its target gene, 3/July/2014, 6.17 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing